Results 131 to 140 of about 6,228,391 (354)

Complete mitochondrial genomes from three species of the genus Peckia (Sarcophagidae) with forensic entomology interest

Mitochondrial DNA. Part B. Resources, 2019
Peckia is one of the most important genera in the Sarcophagidae family of flesh flies. This genus is distributed in Brazil and Latin America, and its species can be used to estimate the Post Mortem Interval (PMI) in forensic investigations.
Susanne Faccin, Anderson Oliveira do Carmo, Patrícia J. Thyssen, Deodália Dias, Maria Teresa Rebelo, Evanguedes Kalapothakis   +5 more
doaj   +1 more source

Non-independence between markers on homoeologous chromosomes in an interspecific allopolyploid cotton RILs population [PDF]

, 2009
Cotton, as the world's main natural textile fibre, is the focus of many studies for genetic improvement of fibre quality. Two allotetraploid (AtDt genome, 2n=4X=52) species dominate world production: G.
Arioli, Tony, Claverie, Michel, Derijcker, R., Jacobs, John, Lacape, Jean-Marc, Llewellyn, Danny, Viot, Christopher   +6 more
core  

Structural biology of ferritin nanocages

FEBS Letters, EarlyView.
Ferritin is a conserved iron‐storage protein that sequesters iron as a ferric mineral core within a nanocage, protecting cells from oxidative damage and maintaining iron homeostasis. This review discusses ferritin biology, structure, and function, and highlights recent cryo‐EM studies revealing mechanisms of ferritinophagy, cellular iron uptake, and ...
Eloise Mastrangelo, Flavio Di Pisa
wiley   +1 more source

Ordering dominant markers in F2 populations [PDF]

Ordering dominant markers in F2 populations is considered a difficult problem. The difficulties arise from the fact that recombinations cannot be observed directly from the data.
Jansen, J.
core   +3 more sources

Organ‐specific redox imbalances in spinal muscular atrophy mice are partially rescued by SMN antisense oligonucleotides

FEBS Letters, EarlyView.
We identified a systemic, progressive loss of protein S‐glutathionylation—detected by nonreducing western blotting—alongside dysregulation of glutathione‐cycle enzymes in both neuronal and peripheral tissues of Taiwanese SMA mice. These alterations were partially rescued by SMN antisense oligonucleotide therapy, revealing persistent redox imbalance as ...
Sofia Vrettou, Brunhilde Wirth
wiley   +1 more source

Biomarkers for Lewy body diseases and other alpha-synucleinopathies in biofluids: current evidence and future directions

Journal of Translational Medicine
Synucleinopathies, including Parkinson’s disease (PD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA), are a group of proteinopathies characterized by neuronal and glial aggregated alpha-synuclein (α-syn) inclusions.
Alice Russotto, Antonio Longobardi, Arianna Ciullini, Federico Angelo Cazzaniga, Merve Begüm Bacınoğlu, Barbara Borroni, Roberta Ghidoni, Fabio Moda, Claudia Saraceno   +8 more
doaj   +1 more source

DNA polymorphisms amplified by arbitrary primers are useful as genetic markers.

Nucleic Acids Research, 1990
John G. K. Williams, A. Kubelik, Kenneth J. Livak, J. Rafalski, S. Tingey   +4 more
semanticscholar   +1 more source

β‐TrCP overexpression enhances cisplatin sensitivity by depleting BRCA1

Molecular Oncology, EarlyView.
Low levels of β‐TrCP (Panel A) allow the accumulation of BRCA1 and CtIP, which facilitate the repair of cisplatin‐induced DNA damage via homologous recombination (HR) and promote tumor cell survival. In contrast, high β‐TrCP expression (Panel B) leads to BRCA1 and CtIP degradation, impairing HR repair, resulting in persistent DNA damage and apoptosis ...
Rocío Jiménez‐Guerrero, Alejandro Belmonte‐Fernández, Mónica González‐Moreno, Laura Rodríguez‐Cordero, Begoña Pérez‐Valderrama, Joaquín Herrero‐Ruíz, Francisco Romero, Carmen Sáez, Miguel Á. Japón   +8 more
wiley   +1 more source

adegenet: a R package for the multivariate analysis of genetic markers

Bioinform., 2008
T. Jombart
semanticscholar   +1 more source

PARP inhibitors elicit distinct transcriptional programs in homologous recombination competent castration‐resistant prostate cancer

Molecular Oncology, EarlyView.
PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham, Jasibel Vasquez‐Gonzalez, Samantha M. Barnada, Salome Tchotorlishvili, Latese Jones, Ryan Maguire, Genevieve Lewis, Kinza Rizwan, Jenny Deng, Salma Koachar, Drithi Patel, Hailey Shankle, Tessa Mulders, Namra Ajmal, Charalambos Solomides, Emad S. Alnemri, Teresa F. Alnemri, Ayesha A. Shafi, Leonard G. Gomella, Wm Kevin Kelly, Steven B. McMahon, Matthew J. Schiewer   +21 more
wiley   +1 more source